BioSpace News Archive

Verve Therapeutics announced that Sekar Kathiresan, M.D., chief executive officer, will be speaking at the 2019 Jefferies Gene Therapy/Editing Summit.

Teva Pharmaceutical Industries announced the retirement of Dr. Carlo de Notaristefani, and the appointment of Eric Drapé as Executive Vice President, Global Operations.

Fibrosis-specific substrates provide a disease-relevant in-vitro testing platform to inform decision-making in early-stage drug discovery

CytoSorbents Corporation announces positive surgical outcomes in a recent publication entitled, “CytoSorb Adsorption During Emergency Cardiac Operations in Patients at High Risk of Bleeding,” in the journal Annals of Thoracic Surgery, ahead of the European Association of Cardio-thoracic Surgery Annual Meeting in Lisbon, Portugal, October 3-5, 2019.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that data, which further demonstrates the potential of ibrexafungerp as a treatment for invasive fungal infections, will be presented at IDWeek 2019, occurring October 2-6, 2019 in Washington DC, and TIMM-9, occurring October 11-14, 2019 in Nice, France

Sonendo®, Inc., developer of the GentleWave® System, announced it had been named a winner of the 2019 OCTANe High Tech Awards for Outstanding Innovation in the Medical Technology category.

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-dosed polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today multiple presentations on metabolic acidosis that will be given at the upcoming American Society of Nephrology (ASN) Kidney Week 2019 meeting taking place November 5-10, 2019 in Washington, D.C.

Company Celebrates 20 Years of Innovation Under Tarek Sherif’s Leadership; Transforming Drug Development and Clinical Trial Technology

DDF celebrated its distinguished Board of Directors, welcomed new Board members, and recognized major contributors to its mission.

CEO Kuldeep Singh Rajput will also speak at CB Insights’ Future of Health conference about what’s ahead for digital therapeutics